RxDoctor Payments Data

Jonathan Massey, MD

Cardiovascular Disease · Kissimmee, FLNPI 1992237218

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (51.0%), food and beverage and education — rather than concentrated in one kind of arrangement. 15 manufacturers reported payments, led by Boston Scientific at 50.1% of the total. Reporting peaked in 2022 at $2,424 and has fallen 71.9% since, to $682 in 2025.

$4,921in general payments, 2019–2025

Across 45 payments — averaging $109.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$2K
  • Edwards Lifesciences$1K
  • Penumbra, Inc.$242
  • Philips North America LLC$240
  • Abiomed$217
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$146
  • plus $293 from 9 others

What the payments were for

  • Travel & lodging$2,51151%
  • Food & beverage$2,40849%
  • Education$10%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,921 in reported general payments places this provider in the 60th percentile of 1,740 cardiovascular disease providers in Florida.

See all cardiovascular disease providers in Florida →

Medicare billing

Part B allowed, 2024
$31,953
Medicare patients
145
Services billed
303

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other cardiovascular disease in Kissimmee

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →